Name | PF-06305591 |
---|
Description | PF-06305591 is a potent and highly selective voltage gated sodium channel NaV1.8 blocker, with an IC50 of 15 nM. An excellent preclinical in vitro ADME and safety profile[1]. |
---|---|
Related Catalog | |
Target |
IC50: 15 nM (NaV1.8)[1]. |
In Vitro | PF-06305591 (compound 9) has a highly attractive profile with respect to NaV selectivity, hERG activity, passive permeability and in vitro metabolic stability[1]. |
In Vivo | PF-06305591 (compound 9) has good rat bioavailability. PF-06305591 offers the possibility of investigating higher IC50 multiples of Nav1.8 blockade in the clinic, and therefore a more thorough evaluation of the role of NaV1.8 in the treatment of pain[1]. |
References |
Molecular Formula | C15H22N4O |
---|---|
Molecular Weight | 274.36 |